Frequency, factors and costs associated with injection site infections: Findings from a national multi-site survey of injecting drug users in England
2008

Injection Site Infections in Drug Users in England

Sample size: 1058 publication Evidence: moderate

Author Information

Author(s): Hope Vivian, Kimber Jo, Vickerman Peter, Hickman Matthew, Ncube Fortune

Primary Institution: Centre for Infections, Health Protection Agency, London, UK

Hypothesis

What are the frequency, factors, and costs associated with injection site infections among injecting drug users in England?

Conclusion

Injection site infections are common among injecting drug users in England, leading to significant healthcare costs.

Supporting Evidence

  • 36% of participants reported an injection site infection in the last year.
  • Two-thirds of those with an infection sought medical advice.
  • Healthcare costs associated with these infections are estimated to be between £15.5 million and £47 million annually.

Takeaway

Many people who use drugs and inject themselves get infections at the injection site, which can cost a lot of money for treatment.

Methodology

An unlinked-anonymous survey was conducted from 2003 to 2005, recruiting injecting drug users from community settings across seven locations in England.

Potential Biases

High-risk individuals may be overrepresented due to recruitment methods focused on needle exchanges and community settings.

Limitations

Self-reported symptoms may not accurately reflect clinical diagnoses, and the sample may not be fully representative of all injecting drug users.

Participant Demographics

{"gender_distribution":{"male":77,"female":23},"age_distribution":{"under_25":18,"over_25":82},"homelessness":{"ever_homeless":86,"last_homeless_within_12_months":59}}

Digital Object Identifier (DOI)

10.1186/1471-2334-8-120

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication